539524 Stock Overview
Operates laboratories for carrying out pathological investigations in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Dr. Lal PathLabs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,688.15 |
| 52 Week High | ₹2,889.45 |
| 52 Week Low | ₹1,943.20 |
| Beta | 0.28 |
| 11 Month Change | 2.36% |
| 3 Month Change | 18.52% |
| 1 Year Change | 23.98% |
| 33 Year Change | -14.55% |
| 5 Year Change | 153.34% |
| Change since IPO | 226.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| 539524 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -2.3% | -0.9% | -0.1% |
| 1Y | 24.0% | 42.3% | 46.3% |
Return vs Industry: 539524 underperformed the Indian Healthcare industry which returned 42.3% over the past year.
Return vs Market: 539524 underperformed the Indian Market which returned 46.3% over the past year.
Price Volatility
| 539524 volatility | |
|---|---|
| 539524 Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 539524's share price has been volatile over the past 3 months.
Volatility Over Time: 539524's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 4,099 | Shankha Banerjee | www.lalpathlabs.com |
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs.
Dr. Lal PathLabs Limited Fundamentals Summary
| 539524 fundamental statistics | |
|---|---|
| Market cap | ₹222.47b |
| Earnings (TTM) | ₹3.58b |
| Revenue (TTM) | ₹22.27b |
62.6x
P/E Ratio10.1x
P/S RatioIs 539524 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 539524 income statement (TTM) | |
|---|---|
| Revenue | ₹22.27b |
| Cost of Revenue | ₹9.48b |
| Gross Profit | ₹12.79b |
| Other Expenses | ₹9.21b |
| Earnings | ₹3.58b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 42.99 |
| Gross Margin | 57.44% |
| Net Profit Margin | 16.07% |
| Debt/Equity Ratio | 4.4% |
How did 539524 perform over the long term?
See historical performance and comparison